David M Goldstein
CIK 1751719 · Chief Scientific Officer · last filed 2026-01-28
David M Goldstein is a Chief Scientific Officer who has filed 11 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for ALMS, was dated Jan 28, 2026. Across all open-market trades the lifetime net is −$1.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $727.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$727.3K
2
11
-$1.64M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALMS | Chief Scientific Officer | 30,115 | $24.15 | $727.3K | $0 | 4 | 2026-01-28 |
| Principia Biopharma Inc. (PRNB) Delisted | Chief Scientific Officer | 0 | — | — | -$1.64M | 7 | 2020-09-28 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-28 | ALMS | Grant (A) | — | $0 | EDGAR |
| 2025-07-31 | ALMS | Grant (A) | +27,000 | $0 | EDGAR |
| 2025-02-20 | ALMS | Grant (A) | — | $0 | EDGAR |
| 2024-07-01 | ALMS | Mixed | — | $0 | EDGAR |
| 2020-09-28 | Principia Biopharma Inc. (PRNB) Delisted | Mixed | −31,826 | -$3.18M | EDGAR |
| 2020-08-12 | Principia Biopharma Inc. (PRNB) Delisted | Mixed | — | -$513.0K | EDGAR |
| 2020-05-08 | Principia Biopharma Inc. (PRNB) Delisted | Mixed | — | -$343.0K | EDGAR |
| 2020-03-05 | Principia Biopharma Inc. (PRNB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-12 | Principia Biopharma Inc. (PRNB) Delisted | Mixed | — | -$407.4K | EDGAR |
| 2019-11-08 | Principia Biopharma Inc. (PRNB) Delisted | Mixed | — | -$305.1K | EDGAR |